Gait impairments in Parkinson's disease

Anat Mirelman, Paolo Bonato, Richard Camicioli, Terry D. Ellis, Nir Giladi, Jamie L. Hamilton, Chris J. Hass, Jeffrey M. Hausdorff, Elisa Pelosin, Quincy J. Almeida

Research output: Contribution to journalReview articlepeer-review

Abstract

Gait impairments are among the most common and disabling symptoms of Parkinson's disease. Nonetheless, gait is not routinely assessed quantitatively but is described in general terms that are not sensitive to changes ensuing with disease progression. Quantifying multiple gait features (eg, speed, variability, and asymmetry) under natural and more challenging conditions (eg, dual-tasking, turning, and daily living) enhanced sensitivity of gait quantification. Studies of neural connectivity and structural network topology have provided information on the mechanisms of gait impairment. Advances in the understanding of the multifactorial origins of gait changes in patients with Parkinson's disease promoted the development of new intervention strategies, such as neurostimulation and virtual reality, aimed at alleviating gait impairments and enhancing functional mobility. For clinical applicability, it is important to establish clear links between specific gait impairments, their underlying mechanisms, and disease progression to foster the acceptance and usability of quantitative gait measures as outcomes in future disease-modifying clinical trials.

Original languageEnglish
Pages (from-to)697-708
Number of pages12
JournalThe Lancet Neurology
Volume18
Issue number7
DOIs
Publication statusPublished - Jul 1 2019

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Gait impairments in Parkinson's disease'. Together they form a unique fingerprint.

Cite this